SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-KSB


[X]  Annual Report pursuant to Section 13 or l5 (d) of the Securities  Exchange
     Act of 1934

                      for the year ended July 31, 2003

                                       OR

[ ]  Transition  Report  pursuant  to Section 13 or 15 (d) of the  Securities
     Exchange  Act of  1934

          for the transition period from ___________ to ___________ .

                         Commission File Number: 333-61538

                            ON THE GO HEALTHCARE, INC.
         ---------------------------------------------------------------
        (Exact Name of Small Business Issuer as Specified in Its Charter)

             DELAWARE                                         98-0231687
             --------                                         ----------
   (State or Other Jurisdiction                            (I.R.S. Employer
  Incorporation or Organization)                        Identification Number)

         85 Corstate Avenue, Unit #1, Concord, Ontario, Canada L4K 4Y2
             ------------------------------------------------------
                    (Address of Principal Executive Offices)

  Registrant's telephone number, including area code: (905) 760-2987

  Securities Registered Pursuant to Section 12(b) of the Act:        None

  Securities Registered Pursuant to Section 12(g) of the Act:        None

                                                        Name of Each Exchange
            Title of Each Class                          on which Registered
            -------------------                         ---------------------
 Common Stock, par value $0.0001 per share                      None

We generated $ 91,584 of gross revenues for the fiscal year ended July 31, 2003
As of September 30, 2003, 38,639,222  shares  of our  Common  Stock  were
outstanding, at a par value of $0.0001 per share.


<PAGE>



                           ON THE GO HEALTHCARE, INC.
                         ANNUAL REPORT ON FORM 10-KSB
                    FOR THE FISCAL YEAR ENDED JULY 31, 2003

                                TABLE OF CONTENTS
PART I                                                                     PAGE

Item 1     Description of Business                                            3
Item 2     Properties                                                         8
Item 3     Legal Proceedings                                                  8
Item 4     Submission of Matters to a Vote of Security Holders                8

PART II

Item 5     Market For Common Equity and Related Stockholder Matters           9
Item 6     Management's Discussion and Analysis or Plan of Operation         10
Item 7     Financial Statements and Supplementary Data                       13
Item 8     Changes in and Disagreements with Accountants on Accounting and
           Financial Disclosure                                              13
Item 8A    Controls and Procedures                                           13

PART III

Item 9     Directors, Executive Officers, Promoters and Control Persons      13
Item 10    Executive Compensation                                            15
Item 11    Security Ownership of Certain beneficial Owners and Management    15
Item 12    Certain Relationships and Related Transactions                    16
Item 13    Exhibits and Reports on Form 8-K                                  16
Item 14    Principal Accountant Fees and Services                            16
           Signatures                                                        17
           Financial Statements                                        F1 - F12



<PAGE>


PART I

ITEM 1. DESCRIPTION OF BUSINESS


                          DESCRIPTION OF BUSINESS


        We incorporated in the State of Delaware on July 21, 2000.
International Mount Company Limited, which was incorporated under the laws of
Canada in August 1993, is our wholly owned subsidiary. We acquired
International Mount on July 21, 2000, through the issuance to its shareholders
of 16,000,000 shares of our common stock, in exchange for all of the issued
and outstanding shares of International Mount's common stock, pursuant to a
Share Exchange Agreement. We conduct business directly and through our
subsidiary.

        Through our subsidiary, International Mount, we are a manufacturer of
healthcare products targeting the home healthcare, medical, rehabilitation and
long-term care markets in Canada. We currently manufacture, market and
distribute portable reusable heating pads, molded cases for pills, condoms and
tampons and a child padded training seat under our own brand names throughout
Canada and the United States.  We maintain manufacturing and distribution
facilities in Canada. We continuously seek to expand our product lines by
increasing our investment in product development, relevant acquisitions, and
through the forming of strategic alliances with other companies. Our primary
marketing strategy is directed towards hospitals, nursing homes, physicians,
home healthcare and rehabilitation re-distributors, as well as both wholesalers
and retailers of healthcare products, including drug stores, catalog companies,
pharmacies, home-shopping related businesses, and certain governmental
agencies. Currently, our primary customers are independent retailers,
franchised drug stores and wholesalers.

        Our principal executive offices are located at 85 Corstate Avenue,
Unit #1, Concord, Ontario, Canada L4K 4Y2. Our telephone number is
(905)760-2987.


On The Go


        On The Go manufactures and markets the following products:

* Pill Carrying Case:  The product is a protective convenient carrying case
  for pills with four (4) individual compartments and secure closure for
  discrete and easy storage.

* Condom Carrying Case:  The product is a protective convenient carrying case
  that holds up to three (3) condoms with secure closure for discrete and
  easy storage.

* Tampon Carrying Case:  The product is a protective convenient carrying case
  that holds two (2) tampons with secure closure for discrete and easy storage.

* Child Padded Training Seat: The product is a padded training seat to make
  the child more comfortable when potty training.  We currently have six
  different designs in the market.

* Packaging Products made from vacuum formed Poly Vinal Cloride, or PVC.


        All On The Go cases are available with textured surface and made of
one piece hinged polypropylene plastic for strength and durability.


Healing Heat Sensation


        Healing Heat Sensation or HHS is a registered division of
International Mount. We manufacture, market and distribute a range of
healthcare products under the HHS brand name. HHS products are marketed to
distributors and other consumers, principally hospitals, nursing homes,
physicians, home healthcare and rehabilitation dealers, healthcare product
wholesalers and retailers, including drug stores, catalogue companies,
pharmacies, home-shopping related businesses and certain governmental agencies.

        Product lines marketed by HHS include therapeutic heat pack products
for the acute care, long-term care and consumer markets. HHS also sells heat
packs through a distribution/dealer network, which includes cart/kiosk
retailing programs located in consumer outlets. HHS's principal product,
Healing Heat Sensation, is not a new invention.  However, prior to 1990 it
was sold primarily as a novelty and hand warmer.  HHS's approach is to focus
primarily on the therapeutic aspects of the products.


Current Product Offerings Include:


* Large  8"X18" Reusable / Portable Heat Pack
* Medium 8"X8"  Reusable / Portable Heat Pack
* Small  4"X10" Reusable / Portable Heat Pack
* Mini   3"X4"  Reusable / Portable Heat Pack


How Healing Heat Sensation Packs Work

        As the Healing Heat Sensation packs change from a resting to a heat
generating state there is an element of visible sensationalism that the
product undergoes.  Simple flexing of the metal disk contained within the
pack starts a crystallization process of the pack contents.  The consumer
can see this process very vividly as they watch the pack crystallize.

        The Healing Heat Sensation pack contains a solution of sodium acetate
and water. Sodium acetate is good for super cooling. It freezes at 130
degrees Fahrenheit or 54 degrees Centigrade, but it exists as a liquid at
a much lower temperature and is extremely stable. Clicking the disk forces
a few molecules to change to a solid state, and the rest of the liquid then
rushes to solidify as well.  The temperature of the solidifying liquid jumps
up to 130 degrees Fahrenheit in the process, while maintaining its flexibility.

                                       3

<PAGE>


        When you boil the crystallized pack you melt it back to the liquid
state. Every crystal must be completely melted or the liquid will quickly
re-solidify. You can repeat this cycle forever theoretically, just as you
can freeze and melt water as many times as you like.  There are no
consumables involved in the conversion process and therefore, nothing to
wear out.   The sealed, plastic containment pouch is constructed of custom
formulated, poly vinyl chloride and when appropriately cared for, can last
forever.

Sales and Marketing


        Our sales and marketing plan target specific markets. We have
established a dedicated sales force comprised of two full time salaried
sales representatives and three independent sales agencies working solely
on commission. We are planning an expansion of our telemarketing program
to enhance the sales and marketing efforts of our sales forces. We hope
to develop an extensive telemarketing program, consisting of telemarketing
sales personnel located in Toronto, Ontario, to target approximately 8,000
business customers, including wholesale distribution networks and retail
drug chains, throughout North America.

        Our products currently do not need to comply with any requirements
imposed by government agencies in our target markets.


        We market our products using a variety of programs and materials
including print advertising, product brochures, cooperative advertising, our
web site, and sales promotions to reinforce our ongoing commitment to satisfy
the needs of our customers.  We plan to develop a product line videotape, a
CD-ROM version of our catalog and an interactive Internet web-site.

Marketing Plan

        Our current three-year sales and marketing plan focuses on:

        (i)     increased representation and sales growth through retail
                locations, wholesale divisions and world-wide Internet
                distribution;
        (ii)    positioning our company as a contender in providing our
                products to our present market (North America), South
                America and other emerging markets, at the most
                economical price;
        (iii)   building on our successful relationships with customers and
                suppliers;
        (iv)    increasing market penetration through business to business
                and web based representation of newly sourced products, and
        (v)     continuing negotiations with target corporations in related
                manufacturing and drug-chain businesses, leading to strategic
                alliances and acquisitions.


        We believe we have developed a solid reputation with our
suppliers.  In the development of our marketing plan, we anticipate building
on our current revenue base and developing our product distribution plans
based on the following key areas of experience and success:

        (i)     strong existing presence in Canada and United States,
        (ii)    the development of distribution network representation in
                South America and emerging countries,
        (iii)   a close working relationship between management and suppliers,
                distributors and retailers,
        (iv)    specialized private labeling for specific customers and
                markets,
        (v)     market penetration in current target markets,
        (vi)    acceptance by leading manufacturers and the trade press,
        (vii)   a well-tested line of quality products, and
        (viii)  quality customer service.

        We also plan to establish an international sales force consisting of
independent commission-only representatives located overseas. In order to
expand our presence in the European, South American, and South African
markets, we will consider opportunities to enter into a multi-year
non-exclusive European, South American and South African distribution
agreements for a range of our products with an original equipment manufacturer
and supplier of medical products. As of October 15, 2003, we have not initiated
our international sales plans nor have we identified a potential partner.
                                       4

<PAGE>

Strategic Alliances


        An important part of our strategy is to develop relationships with
manufacturers who wish to significantly increase their own product sales
through a network of distributors and drug-chains offering high demand
products at reasonable prices. We believe we will be able to capitalize
on manufacturers' product marketing programs, sales forces and
distribution strategies.


        We have entered into a Cross Distribution arrangement with Vital
Baby Innovations to distribute their line of Heinz Baby Basics Feeding
Accessories which includes bottles, bibs and tableware for infants and toddlers
within Canada and for them to distribute our padded training seat worldwide.


Wholesale Operations


        We intend, in certain markets, to wholesale product lines other than
those that will carry the HHS or On the Go labels.  Because of our large
purchasing power, we believe that we have the ability to make large volume
purchases of manufacturer's clearance and ends-of-lines and the infrastructure
to add bottom line value while levering off of these products.

        The products we intend to add fall into two categories:
        (i)     accessories for our own products, such as, heat pad pouchs and
                straps, and
        (ii)    baby products that are more economical to source locally.

Competition


       We compete with other manufacturers and distributors who offer one or
more products competitive with the HHS products and our padded training seat.
However, we believe that no single competitor serving our markets offers as
competitive a product as ours. Our principal means of competition are our
quality, reliability, and value-added services, including delivery and service
alternatives. We believe that these attributes combined with technological
advances relating to our manufactured and proprietary products are favorable
factors in competing with other manufacturers such as:

               * Reheater, USA and Hood Thermo-Pad Canada Ltd, Canada;
               * Prism Enterprise, USA;
               * Ginsey Inc.;
               * Doral Juvenile group;
               * The First Years Inc.; and
               * Mommy's Helper Inc.

                                      5

<PAGE>


Customers


        The HHS products are marketed principally to hospitals, nursing homes,
physicians, home healthcare and rehabilitation dealers, healthcare product
wholesalers and retailers, including drug stores, catalog companies,
pharmacies, home-shopping related businesses and certain governmental
agencies.  We also market and sell our products to the consumer market
by distribution into drug store chains, mass merchandisers and department
stores. Consumers who purchase from such stores usually do so upon the
advice of physicians, hospital discharge planners, nurses or other
professionals. We believe that within 24 months we will be able to sell
to substantially all significant channels available in North America.
In general, the dealers, wholesalers and retailers to whom we market our
products also sell other similar products, some of which compete with our
products.


        We do not depend on one or even a few major customers. We sell our
products to customers of all sizes, from cart operators to large national
chain pharmacies. As of October 15,2003, our current revenue mix is estimated
to be 70% from large national pharmacies, 20% from independent retailers and
10% from wholesalers.  Currently our products are in over 500 locations across
North America.


Distribution/Dealer Network

        We have relationships with Dan Z & Company, Bortstein Associates  and
Juvenile Solutions Inc. to market our training seat in the United States.

        We provide same-day and next-day services to our customers through our
distribution network. We believe that our ability to continue to grow our
revenue base depends in part upon our ability to provide our customers with
efficient and reliable service.


        As of October 15, 2003, we distributed our products through one
primary point of distribution located in Concord, Ontario, Canada. We plan
to distribute our products from other distribution facilities if and when
required. However, we have not committed our resources at this time for any
additional distribution facilities.


Manufacturing and Product Sourcing


        We design and manufacture our principal products including HEALING HEAT
SENSATION reusable, portable heating packs and the On The Go Padded Training
Seat. The raw materials include, but are not limited to; custom formulated Poly
Vinal Cloride, or PVC, Acrylonitrile Butadiene Styrene, Polypropylene, sodium
acetate and water.  Our operations rely on a just-in- time, or JIT,
manufacturing processes. With JIT, our production is triggered by immediate
customer demand and our inventories of finished good are either nonexistent
or kept to a minimum. We only build products to meet a customer's shipment
schedule.  Our inventory requirements are therefore minimized and we only
stock special order raw materials, ie., custom formulated PVC. All other
supplies used in the manufacturing process are readily available from any
number of local suppliers, at competitive prices and delivered within 24 hours
in most cases.



        There is no environmental liability associated with the production of
our products. The main products used in the heating pads are sodium acetate
and water. Sodium acetate is a food additive used, for example, in salt and
vinegar chips, and therefore prevents no environmental risk. Further, there
are no special handling instructions for shipment, storage or disposal. Our
chemicals, which are classified as USPFCC (or Food Grade) are not considered
hazardous in the Unites States or Canada. There can be no damages from their
use or misuse, nor are they currently being studied for environmental hazard
potential.

                                       6

<PAGE>

Trademarks


        We believe that our business is dependent in part on its ability to
establish and maintain patent protection for its proprietary technologies,
products and processes, and the preservation of its trade secrets. We
currently have not applied and do not hold any patents relating to any of
our product lines.

        We have registered the business name of Healing Heat Sensation as
a division of the International Mount Company Ltd. under the laws of Ontario,
Canada. The registration provides us solely with another registered name to
do business under, but does not provide us with protection for the products
manufactured under that name.


        We have one trademark in Canada for "ON THE GO". The registered
trademark is significant to us because it will provide us with name and
market recognition for our products and distinguish our products from
our competitors' products. However, we presently have no plans to protect
the name of Healing Heat Sensation.


Governmental Regulation


        The healthcare industry is affected by extensive government
regulation at the Federal, provincial, and state levels. In addition, through
the Ontario Health Insurance Plan or OHIP, Medicare, Medicaid and other
programs the Federal, provincial, and state governments are responsible for
the payment of a substantial portion of the Canadian and United States
healthcare expenditures. Changes in regulations and healthcare policy occur
frequently and may impact the current results of the growth potential for and
the profitability of our products in each market. Although we are not a direct
provider under OHIP, Medicare and Medicaid, many of our customers are
providers under these programs and depend upon such governmental agency's
reimbursements for a portion of their revenue. Changes in regulations may
adversely impact our revenues and collections indirectly by reducing the
reimbursement rate our customers receive and consequently placing downward
pressure on prices charged for our products.


        The Federal Food, Drug and Cosmetic Act and regulations issued or
proposed thereunder provide for regulation by the Food and Drug Administration
or FDA of the marketing, manufacturing, labeling, packaging and distribution
of medical devices and drugs. Our current products do not require FDA approval.
Among these regulations are requirements that medical device manufacturers
register with the FDA, list devices manufactured by them and file product
incident reports. They also have product labeling requirements, and premarket
notification filings for certain product classes. We are not required, at
this time, to comply with the FDA's "Current Good Manufacturing Practices for
Medical Devices" regulations, which set forth requirements for, among other
things, our quality system for the manufacturing and distribution operations.


        Current FDA regulations have no impact on us and we do not have any
specific plans to manufacture any prodcuts at this time that might be subject
to FDA regulations. However, this may change in future years as we expand our
product line and increase our manufacturing operations. To date, we do not
have the need to comply with the requirements  imposed by the FDA or other
United States or Canada government agencies. Notwithstanding, we believe
that the manufacturing and quality control procedures we employ substantially
conform to the requirements of the FDA.

                                       7

<PAGE>


Product Development


        We have set forth the following goals for the next 12 months and
beyond:

* extend our product line to include additional products made from plastic
  injection moulding.
* add more functions and features to our current Web site,
  www.onthegohealthcare.com, to give our clients the ability to order
  products or services using the Internet.
* be in a position to meet any unique client requirements for product
  customization or packaging as needed.
* enhance our (EDI) electronic data capabilities which enable us to communicate
  more efficiently with our customers.

        We have not conducted any research on new products over the past
two fiscal years. The outcome of our products were known in advance, therefore
no research was needed. We have only conducted routine product development
over the past two fiscal years. During such period, we have spent approximately
$5,000 on routine product development that includes the construction of
moulds, dies and machinery used in the manufacturing of our current products.


Employees


        As of October 15, 2003, we had 3 full time employees and 3
subcontractors.  Management believes its relations with employees is good. None
of the employees are covered by any collective bargaining agreement. We do not
anticipate any significant change to our employee base over the next 12 months.


ITEM 2. PROPERTIES

        We are headquartered in Toronto, Ontario, Canada where we lease a
6,500 square foot facility in support of our marketing, manufacturing and
distribution requirements. We have issued 150,000 shares pursuant to a
15-month lease that expires in January 2004. We believe this facility is
adequate for our needs for the next year.

        We manufacture and ship our products directly from our head office.



ITEM 3. LEGAL PROCEEDINGS

        Neither we nor our officers or directors are a party to any
litigation affecting us or our assets or any of our subsidiaries. No such
litigation has been threatened, or is known to be contemplated by any person.



ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

        None.

                                       8

<PAGE>


                                     PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

 Our common stock has traded over the counter and has been quoted on the OTC
Bulletin Board since February 5, 2003. The stock currently trades under the
symbol"OGHI"

     The following  table sets forth the range of high and low bid quotations as
reported by the National  Association of Securities Dealers for the common stock
of the  Company  for the last two  fiscal  years.  Quotations  represent  prices
between dealers, do not include retail markups,  markdowns or commissions and do
not necessarily represent prices at which actual transactions were effected.

Year Ended                  High            Low
------------------         ------          -----

2003
--------
April 30                   $ .15           $ .02
July 31                    $ .18           $ .082



     The number of record holders of our common stock as of September 30, 2003
was approximately 480.  There are 38,639,222 shares of the Company's common
stock issued and outstanding as of such date.

        From the year ended July 31, 2001 to the date of the prospectus, we
have sold the following unregistered securities:

        During the year ended July 31,2001,we successfully completed a $464,625
private placement of 1,858,500 shares of our common stock to certain investors.

        On July 1, 2002, we issued 11,000,000 common shares in settlement of a
loan payable to a related party in the amount of $60,017.

        During the year ended  July 31, 2002, we issued 380,000 common shares
at a price of $.25 per share. Issue costs totalling $153,874 were charged
against the proceeds of this share issuance.

        On July 1, 2002, we issued 75,000 common shares to each of 5 directors
and officers of the company for a total issuance of 375,000.

        We have signed an agreement that for the period November 1, 2002
to January 31, 2004 rent will be paid for by the issuance of 10,000 common
shares per month in lieu of rent. 150,000 shares have been issued in
satisfaction of this agreement.

        In April 2003, we issued  1,000,000 common shares to Stuart Turk for
compensation and 1,000,000 shares of common stock to The Cellular Connection
Ltd. for use of equipment.

        In July 2003, we issued 1,000,000 common shares as consideration
for services rendered to NFC Corporation.

        In July 2003, we issued 500,000 common shares as consideration
for services rendered to 964434 Ontario Inc.

        On July 31, 2003, we issued 75,000 common shares to each of 5 directors
and officers of the company for a total issuance of 375,000.

        On July 31, 2003, we issued  230,000 common shares to Stuart Turk
for compensation.

        The securities issued in the foregoing transactions were either
(i) offered and sold in reliance upon exemptions from the Securities
Act of 1933 ("Securities Act") registration requirements set forth in
Sections 3(b) and 4(2) of the Securities Act, and any regulations
promulgated thereunder, relating to sales by an issuer not involving
any public offering, or (ii) in the case of certain options to purchase
shares of common stock and shares of common stock issued upon the
exercise of such options, such offers and sales were made in reliance
upon an exemption from registration under Rule 701 promulgated under
Section 3(b) of the Securities Act. No underwriters were involved in
the foregoing sales of securities


       There were no underwriters in the foregoing transactions.

       Our board of directors does not anticipate paying cash dividends
on our common stock in the foreseeable future. We intend to retain our future
earnings, if any, to finance the growth of our business. The payment of
future cash dividends on our common stock will depend on such factors as
earnings levels, anticipated capital requirements, our operating and
financial condition and other factors deemed relevant by our board of
directors.

                                      9

<PAGE>



ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

                   MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                FINANCIAL CONDITION AND RESULTS OF OPERATIONS

        This report contains statements that are not historical facts and which
are "forward looking statements" within the meaning of Section 27A of the
Securities Act of 1933, as amended and Section 21E of the Securities and
Exchange Act of 1934, as amended.  Our financial and business results involve
risks and uncertainties that could cause actual results to differ from
projected results.  Such statements address activities; events or developments
that we expect, believe, project, intend or anticipate will or may occur,
including such matters as future capital, business strategies, expansion and
growth of our operations and future net cash flows.  Factors that could cause
actual results to differ materially are described throughout this statement.
Cautionary disclosures include, among others: general economic conditions, the
markets for and market price of our products, the strength and financial
resources of our competitors, our ability to find and retain skilled personnel,
the results of financing efforts and regulatory developments and compliance.
We disclaim any obligation to update or revise any forward-looking statement
to reflect events or circumstances occurring hereafter or to reflect the
occurrence of anticipated or unanticipated events, other than as required
by law.


General

We have a limited operating history and conduct our operations through our
wholly owned subsidiary, International Mount, which manufactures and sells a
line of home healthcare products targeting the home healthcare, medical,
rehabilitation and long-term care markets under the brand name Healing Heat
Sensation. We also manufacture a line of childrens products and market them to
chain drug stores and independent retailers around the world.

On July 21, 2000, we acquired International Mount via a cash payment of $198
and the exchange of 16,000,000 shares of our common stock for all of the
outstanding stock of International Mount. As both companies were under common
control of Mr. Stuart Turk at the time of the merger, the transaction was
accounted for at historical cost in a manner similar to that in pooling of
interests accounting and our consolidated financial statements reflect the
combined results of the company and its wholly owned subsidiary International
Mount. Our fiscal year end is July 31.   International Mount began its
operations in August 1993. This gave International Mount the ability to
initiate its operations in the market niches that we are currently exploiting
today in the manufacture and sale of home healthcare and childrens products.
As a whole, we have successfully used our market niches to obtain investment
returns that we believe were and are available.


Critical Accounting Policies and Estimates

        The preparation of financial statements and related disclosures in
conformity with accounting principles generally accepted in the United States
requires management to make estimates and assumptions that affect the amounts
reported in the Consolidated Financial Statements and accompanying notes.
Estimates are used for, but not limited to, the accounting for the allowance
for doubtful accounts, inventories, income taxes and loss contingencies.
Management bases its estimates on historical experience and on various other
assumptions that are believed to be reasonable under the circumstances. Actual
results could differ from these estimates under different assumptions or
conditions.

        We believe the following critical accounting policies, among
others, may be impacted significantly by judgment, assumptions and estimates
used in the preparation of the Consolidated Financial Statements:

        We recognize revenue in accordance with Securities and
Exchange Commission Staff Accounting Bulletin No. 101, "Revenue Recognition in
Financial Statements" ("SAB 101"). Under SAB 101, revenue is recognized at the
point of passage to the customer of title and risk of loss, there is persuasive
evidence of an arrangement, the sales price is determinable, and collection of
the resulting receivable is reasonably assured. We generally recognize revenue
at the time of shipment. Sales are reflected net of discounts and returns.

                                      10

<PAGE>


        The allowance for doubtful accounts is maintained to provide for losses
arising from customers' inability to make required payments. If there is a
deterioration of our customers' credit worthiness and/or there is an increase
in the length of time that the receivables are past due greater than the
historical assumptions used, additional allowances may be required.

        Inventories are stated at the lower of cost (determined on an average
cost basis) or market. Based on our assumptions about future demand and market
conditions, inventories are written-down to market value. If our assumptions
about future demand change and/or actual market conditions are less favorable
than those projected, additional write-downs of inventories may be required.

        Deferred tax assets are recorded based on our projected future taxable
income and the resulting utilization of the deferred tax assets.  To the
extent that it is more likely than not that  we would not be able to realize
all or part of our deferred tax assets in the future, an adjustment to the
deferred tax assets would be necessary and charged to income.

        Loss contingencies arise in the ordinary course of business. In
determining loss contingencies, we evaluate the likelihood of the loss or
impairment of an asset or the incurrence of a liability, as well as our ability
to reasonably estimate the amount of such loss. We accrue for an estimated loss
contingency when it is probable that a liability has been incurred or an asset
has been impaired and the amount of the loss can be reasonably estimated.

        Amounts billed to customers for shipping and handling are recorded as
sales revenues. Costs incurred for shipping and handling are included in cost
of sales.

        Discounts and point-of-sale rebates are offered to our customers on our
products. The costs of these discounts and point-of-sale rebates are recognized
at the date at which the related sales revenue is recognized and are recorded
as a reduction of sales revenue.





Results of Operations

For the Fiscal Years Ended July 31, 2003 and July 31, 2002


Revenues

        Revenues increased from $75,993 for the year ended July 31, 2002
to $91,584 for the year ended July 31, 2003. The increase in revenues is mainly
attributable to the efforts of our sales force in increasing the number of
retail outlets carrying our products.

Selling, General and Administrative Expenses

        Expenses increased by $167,511 from $169,666 for the year ended
July 31, 2002 to $337,177 for the year ended July 31, 2003. The increase can be
mainly attributed to the increase in consulting fees and management salaries in
the year ended July 31, 2003.


Net and comprehensive loss

        We experienced an increase in our net loss of approximately $260,000
from approximately $129,000 for the year ended July 31, 2002 to a net loss of
approximately $389,000 for the year ended July 31, 2003. The comprehensive loss
increased by $226,000 from $145,000 to $371,000. Among the significant items
impacting the 2003 results was the increase in consulting fees and management
salaries and the valuation allowance for deferred income taxes.

The weighted average shares outstanding for the year ended July 31, 2003 was
31,540,363 an increase of 12,478,113 shares over the weighted average shares
outstanding for the year ended July 31, 2002 of 19,062,250.

                                      11

<PAGE>



Liquidity and Capital Resources

        Current assets totaled $217,516 at July 31,2003 an increase of $158,972
as compared to $58,544 at July 31, 2002. The increase in primarily attributable
to the prepaid portion of consulting agreements reflected in prepaid expenses
and the increase in accounts receivable and inventory related to the increase
in volume.

        Current liabilities totaled $60,918 at July 31, 2003 an increase of
$6,733 as compared with $54,185 at July 31, 2002. The increase was attributable
to payables incurred for inventory acquisitions.

        For both the years ended July 31, 2003 and 2002, we used $0 of cash
for investing activities.

        For the year ended July 31, 2003, we had cash provided by financing
activities of $95,819, as compared to cash provided by financing activities of
$136,899 for the year ended July 31, 2002. The current primary source of
financing has been advances from related parties which was $41,727 in the year
ended July 31, 2002 as compared to $102,682 in the year ended July 31, 2003.
In the year ended July 31, 2002, we received proceeds of $95,148 for
the issuance of common stock.

        To July 31, 2003, we have not been profitable and have
experienced negative cash flows from operations. Operations have been financed
through the issuance of stock, loans provided by related parties and other
external financing.

        On July 21, 2003, we signed an agreement for the issuance of common
shares pursuant to an equity line of credit agreement. The quantity of shares
to be issued will be limited by the volume of shares traded and the price will
be determined at 94% of the average of the three lowest closing best bids
during the pricing period. We believe that we have sufficient funds to fund
our operations for a minimum of 12 months. Our short term operating
requirements are between $5,000 and $6,000 per month to cover salaries, rent,
gas, utilities and miscellaneous operating expenses. We can support our short
term requirements by the sale of 25 to 35 pieces of product per day.
Currently, we are selling 40 to 80 pieces of product per day and have a
minimum of four months of inventory on hand in raw and finished goods.
Therefore, management believes that we will have sufficient funds to cover
our short term operating and capital requirements. Our long term operating
requirements are between $20,000 and $30,000 to cover our operating expenses
including increased expenses for sales and marketing and hiring of additional
personnel. Funds to cover our long term requirements will be taken from funds
generated from operations and proceeds from the equity line of credit.




                                       12
<PAGE>



ITEM 7. FINANCIAL STATEMENTS

Our financial statements, including the notes thereto, together with the report
of Rosenberg Smith & Partners C.A.independent auditors thereon,  are presented
following the signature page.



ITEM 8. CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING  AND
        FINANCIAL DISCLOSURE

None


ITEM 8A. CONTROLS AND PROCEDURES

        (a) Evaluation of Disclosure Controls and Procedures.

        Our Chief Executive Officer and Chief Financial Officer
        evaluated the effectiveness of our disclosure controls
        and procedures as of the end of the period covered by this Annual
        Report on Form 10-KSB. Based on this evaluation, the Chief Executive
        Officer and Chief Financial Officer concluded that our disclosure
        controls and procedures are effective to ensure that information we
        are required to disclose in reports that we file or submit under
        the Securities Exchange Act of 1934 is recorded, processed, summarized
        and reported within the time periods specified in Securities and
        Exchange Commission rules and forms.

        (b) Changes in Internal Control.

        There was no change in our internal control over financial reporting
        that occurred during the fourth fiscal quarter of the fiscal year
        covered by this Annual Report on Form 10-KSB that materially affected,
        or is reasonably likely to materially affect, our internal control
        over financial reporting.



ITEM 9.  DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS

The  following  table sets forth  certain  information  about our directors and
executive officers.

<TABLE>
<CAPTION>
Name                            Age        Position (All held as of inception)
-------------------------------------------------------------------------------
<S>                            <C>        <C>
Stuart Turk (1)                 34         President,Chairman, CEO and Director

Evan Schwartzberg, BA, CCM      36         Chief Financial Officer

Ralph Magid, B.A.Sc.,           55         Director
MBA, P.Eng, P.E.O

Randal A. Kalpin                42         Director

Carol Segal (1)                 51         Secretary and Treasurer
-------------------------------------------------------------------------------
</TABLE>
(1) Ms. Segal is Mr. Turk's aunt.


                                       13

<PAGE>

Biographies of executive officers and directors



        Stuart Turk, Chairman, President and CEO. Mr. Turk has been our
president since inception.  Mr. Turk founded The Cellular Connection Ltd.,
a manufacturer of mounting accessories and packaging for cellular phones in
May 1988. He currently serves as the CEO of The Cellular Connection.

        Evan Schwartzberg, BA, CCM. Chief Financial Officer.  Currently, and
since 2000, Mr. Schwartzberg has worked for the TD Bank Financial Group as a
Senior Cash Manager (previously the Manager of Corporate Cash Management of
Canada Trust) within the Treasury and Balance Sheet Management group of the
Finance Division. Prior to such time, and since 1989, Mr. Schwartzberg was a
Senior Cash Manager of Canada Trust. Mr. Schwartzberg holds an Economics
degree from the University of Toronto, passed the Canadian Securities Course
(CSC), from the Canadian Securities Institute, and earned the Certified
Cash Manager (CCM) designation from the Association for Financial
Professionals, a US based organization.


        Ralph Magid, B.A.Sc., MBA, P.Eng., P.E.O., Director. Currently, and
since 1993, Mr. Magid has been the secretary and treasurer of Tipton Realty,
a development company. Mr. Magid is also currently, and since 1998, the
president of Innotech Capital Corp., a company which assists with research
and development grants.  Mr. Magid has more than 25 years of experience in
manufacturing and operations, both in Canada and internationally. Mr. Magid
holds a B.A.Sc. and an MBA  from York University and a P.Eng. from the
University of Toronto. Mr. Magid is a member of the Professional Engineers
of Ontario

        Randal A. Kalpin, Director.  Currently, and since 1989, Mr. Kalpin
has been the President and CEO of Compuquest Inc. a Toronto based company.
Compuquest addresses the computer sales and service needs of corporate Canada.
Mr. Kalpin graduated with honors from York University with a B.A. in 1984.

        Carol Segal, Secretary and Treasurer. Presently, and since 1987,
Ms. Segal is a group leisure travel consultant with the Travel Network Corp.
In addition, Ms. Segal was an agent with TA Connell Real Estate from 1987 to
1997. Ms. Segal has over 20 years of experience in business.

     Directors  serve  for a term of one year or until their successors are
elected and qualified. Executive officers are appointed by and serve at the
will of the Board of Directors.



                                       14


<PAGE>

ITEM 10. EXECUTIVE COMPENSATION

Set forth in the following table is certain information relating to the
remuneration we paid during the past fiscal year to our Chief Execeutive
Officer.  No other executive officers had total
compensation that exceeded $100,000.


                           Summary Compensation Table

                                                            Annual Compensation
<TABLE>
<CAPTION>
                                          Year    Salary    Bonus     All Other
                                                                   Compensation
-------------------------------------------------------------------------------
<S>                                       <C>     <C>      <C>      <C>
Stuart Turk,
President, Chairman, CEO and Director     2001    $80,000   $  -0-   $    -0-
                                          2002    $ 1,500   $  -0-   $    409
                                          2003    $  -0-    $  -0-   $ 46,150
-------------------------------------------------------------------------------
</TABLE>
(1)We issued Mr.Turk 75,000 shares as director's compensation in 2002 and 2003.
   Additionally we issued 1,230,000 common shares for services as Chairman and
   CEO in 2003.


ITEM 11.  SECURITIES OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

     The following table sets forth certain information regarding the
beneficial ownership of shares of our common stock as of October 15, 2003
(i) each stockholder that we know to own beneficially 5% or more of our
outstanding shares of common stock, (ii) each current member of our Board of
Directors, (iii) each executive officer named in the Summary Compensation
Table, and (iv) all directors and executive officers as a group. The
calculation of percentage ownership for each listed beneficial owner is
based upon the number of shares issued and outstanding as of
September 30, 2003.  Except as otherwise indicated below, to our knowledge,
all persons listed below have sole voting and investment power with respect
to their shares of common stock.


Name and Address of
Beneficial Owner (1)                  Number of Shares               Percent
--------------------                  ----------------             ---------
Stuart Turk (2)                             27,580,000                71.38%
Evan Schwartzberg                              150,000                    *
Ralph Magid                                    150,000                    *
Randal A. Kalpin                               150,000                    *
Carol Segal                                    150,000                    *


Directors and executive officers
 as a group (5 persons)                     28,180,000                72.90%

* Less than one percent
(1) The address of such person is 85 Corstate Ave Unit#1 Concord, Ontario,
    L4K 4Y2

(2) Such person may be deemed to be the owner of 12,000,000 common shares by
    virtue of his being a control person and sole owner of The Cellular
    Connection Ltd.


                                       15


<PAGE>

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

     Certain employees, officers, directors, and affiliates were granted
restricted common shares on July  31, 2003. The granting of the shares
for their services have been very favorable to us as these services
are necessary and are provided at no monetary cost to us.


   1 Evan Schwartzberg, our Chief Financial Officer, received 75,000 shares
     for services rendered.

   2 Ralph Magid, our Director, received 75,000 shares for services rendered.

   3 Randal A. Kalpin, our Director, received 75,000 shares for services
     rendered.

   4 Carol Segal, our Secretary and Treasurer, received 75,000 shares for
     services rendered.


ITEM 13.  EXHIBITS REPORTS ON FORM 8-K AND FINANCIAL STATEMENTS

     INDEX OF EXHIBITS


    3.1  Articles of Incorporation of On The Go Healthcare, Inc. included as
         Exhibit 3.1 to our Form SB-2 filed on May 24, 2001 and incorporated
         herein by reference.

    3.2  Articles Of Incorporation of International Mount Company Ltd. included
         as Exhibit 3.2 to our Form SB-2 filed on May 24, 2001 and incorporated
         herein by reference.

    3.3  Articles Of Amendment of International Mount Company Ltd included as
         Exhibit 3.3 to our Form SB-2 filed on May 24, 2001 and incorporated
         herein by reference.

    3.4  By-laws of On The Go Healthcare, Inc. included as Exhibit 3.4 to our
         Form SB-2 filed on May 24,2001 and incorporated herein by reference.

    3.5  By Laws of International Mount Company Ltd. Pages 1-19 included as
         Exhibit 3.5 to our Form SB-2 filed on May 24, 2001 and incorporated
         herein by reference.

    3.6  By Laws of International Mount Company Ltd. Borrowing included as
         Exhibit 3.6 to our Form SB-2 filed on May 24, 2001 and incorporated
         herein by reference.

    4.1  Stock Specimen included as Exhibit 4.1 to our Form SB-2 filed on
         May 24, 2001 and incorporated herein by reference.

   10.1  Lease between On The Go Healthcare, Inc. and 1112396 Ontario Ltd.
         included as Exhibit 10.1 to our Form 10QSB filed on March 10, 2003
         and incorporated herein by reference.

   10.2  Equity Line of Credit Agreement, dated July 21, 2003, by and between
         On The Go Healthcare, Inc. and Dutchess Private Equities Fund, L.P.
         included as Exhibit 10.2 to our Form SB-2 filed on July 22, 2003 and
         incorporated herein by reference.

   10.3  Registration Rights Agreement, dated July 21, 2003 by and between
         On The Go Healthcare, Inc. and Dutchess Private Equities Fund, L.P.
         included as Exhibit 10.3 to our Form SB-2 filed on July 22, 2003 and
         incorporated herein by reference.

   10.4  Placement Agent Agreement, dated July 21, 2003 by and among
         On The Go Healthcare, Inc., Dutchess Private Equities Fund, L.P.
         and Pennaluna and Company included as Exhibit 10.4 to our
         Form SB-2 filed on July 22, 2003 and incorporated herein by
         reference.

   31.1* Section 302 Certification of the Chief Executive Officer.

   31.1* Section 302 Certification of the Chief Financial Officer.

   32.2* Section 906 Certification of the Chief Executive Officer

   32.2* Section 906 Certification of the Chief Financial Officer.

*Filed herein

        (b) REPORTS ON FORM 8-K

                We filed an 8-k on July 22, 2003
                We filed an 8-k on October 22, 2003


        (c) Financial Statements and Schedules


ITEM 14 PRINCIPAL ACCOUNTANT FEES AND SERVICES

        Audit Fees.  The aggregate fees billed by our auditors to date, for
        professional services rendered for the audit of our annual
        financial statements for the years ended July 31, 2003 and
        July 31, 2002 and for the reviews of the financial statements included
        in our Quarterly Reports on Form 10-QSB during those fiscal
        years were approximately $4,000 and approximately $10,000, for the
        respective years ended July 31, 2003 and July 31, 2002.  The amount
        for the year ended July 31, 2003 does not include unbilled amounts for
        the year end audit which are estimated at approximately $1,000.

        Tax Fees. Fees billed by our auditors for the preparation of corporate
        income tax returns were $500 and $500  for the years ended
        July 31, 2003 and 2002, respectively.

        All Other Fees. For the fiscal year ended July 31, 2003 the company
        incurred no other fees by our auditors

        The Audit Committee has considered whether the provision of non-audit
        services is compatible with maintaining the principal accountant's
        independence.

                                        16


<PAGE>



                                   SIGNATURES

In accordance with the  requirements of the Exchange Act of 1934,the registrant
caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

Dated: October 24, 2003


                                              ON THE GO HEALTHCARE, INC.

                                              By:/s/ Stuart Turk
                                              --------------------------------
                                              Stuart Turk, President


In accordance with the  Exchange Act of 1934 this report has been signed
by the following  persons on behalf of the registrant and in the capacities and
or the duties indicated.



Signature                       Title                                   Date


By:/s/ Stuart Turk                                                    10/24/03
------------------------        President, Chief Executive Officer,   --------
Stuart Turk                     Chairman and Director

By:/s/ Evan Schwartzberg        Chief Financial Officer and           10/24/03
------------------------        Accounting Officer                    --------
Evan Schwartzberg

By:/s/ Ralph Magid              Director                              10/24/03
------------------------                                              --------
Ralph Magid

By:/s/ Randal A. Kalpin         Director                              10/24/03
------------------------                                              --------
Randal A. Kalpin




                                       17





                          On the Go Healthcare, Inc.

                      Consolidated Financial Statements











                                  Contents


Independent Auditors' Report on Consolidated Financial Statements............F1

Consolidated Financial Statements:

  Consolidated Balance Sheet as of July 31, 2003 and July 31, 2002...........F2

  Consolidated Statements of Operations and Comprehensive (loss) Income
    for the years ended July 31, 2003 and 2002...............................F3

  Consolidated Statements of Shareholders' Equity as of July 31, 2003
    and July 31, 2002........................................................F4

  Consolidated Statements of Cash Flows for the for the years
    ended July 31, 2003 and 2002.............................................F5

  Notes to Consolidated Financial Statements.............................F6-F12

<PAGE>

                [Letterhead of Rosenberg Smith & Partners]
                     Independent Auditors' Report




                     Independent Auditors' Report



Board of Directors and Shareholders of
On the Go Healthcare, Inc.
Concord, Ontario
Canada


We have audited the accompanying consolidated balance sheet of On the Go
Healthcare, Inc. as of July 31, 2003 and July 31, 2002 and the related
consolidated statements of operations, changes in stockholders' equity,
and cash flows for the years ended July 31, 2003 and July 31, 2002.
These consolidated financial statements are the responsibility of the
management of On the Go Healthcare, Inc.  Our responsibility is to
express an opinion on these consolidated financial statements based on
our audits.

We conducted our audits in accordance with auditing standards generally
accepted in the United States of America.  These standards require that
we plan and perform the audits to obtain reasonable assurance about whether
the consolidated financial statements are free of material misstatement.
An audit includes examining, on a test basis, evidence supporting the
amounts and disclosures in the consolidated financial statements. An audit
also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall consolidated
financial statement presentation.  We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of On the
Go Healthcare, Inc. as of July 31, 2003 and 2002 and the results of its
operations and its cash flows for the years ended July 31, 2003 and
July 31, 2002  in conformity with accounting principles generally accepted
in the United States of America.



Rosenberg Smith & Partners
Chartered Accountants
Concord, Ontario
September 12, 2003

                                                                            F1
<PAGE>




                               On the Go Healthcare, Inc.
                               Consolidated Balance Sheet
                             As of July  31, 2003 and 2002

Assets
                                                         ---------   ---------
                                                              2003        2002
                                                         ---------   ---------
Current assets:
        Cash                                             $     762     $     0
        Accounts receivable                                 21,760       8,203
        Inventory                                           78,197      48,763
        Prepaid expenses                                   116,797       1,578
                                                         ---------   ---------
Total current assets                                       217,516      58,544
                                                         ---------   ---------

Property and equipment, net of accumulated depreciation     40,167      50,375
                                                         ---------   ---------
Other assets:
        Deferred income taxes                                    0      88,191
        Capitalized web site development costs,
         net of accumulated amortization                         0       4,221
                                                         ---------   ---------

Total other assets                                               0      92,412
                                                         ---------   ---------

Total assets                                             $ 257,683    $201,331
                                                         =========    ========


Liabilities and Stockholders' Equity
Current liabilities:
        Bank indebtedness                                $  12,457    $ 12,811
        Accounts payable and Accrued expenses               48,461      41,374
                                                         ---------   ---------
Total Current liabilities                                   60,918      54,185
Notes payable to related parties                           125,947      20,846
                                                         ---------   ---------
Total liabilities                                          186,865      75,031
                                                         ---------   ---------


Stockholders' equity:
        Common stock;$.0001 par value;50,000,000 shares
          authorized; 37,653,500 and 29,613,500 issued
          and outstanding at July 31,2003 and July 31,2002
          respectively                                       3,766       2,962
        Additional paid-in capital                         794,075     457,958
        Treasury stock                                     (21,243)          0
        Accumulated other comprehensive (loss)                (965)    (18,489)
        Accumulated deficit                               (704,815)   (316,131)
                                                         ---------   ---------
Total stockholders' equity                                  70,818     126,300
                                                         ---------   ---------
                                                         $ 257,683    $201,331
                                                         =========   ==========


The accompanying notes are an integral part of these consolidated
financial statements.                                                        F2

<PAGE>

                               On the Go Healthcare, Inc.
         Consolidated Statements of Operations and Comprehensive (loss) Income
                       For the years ended July 31, 2003 and 2002



                                                      ------------  -----------
                                                             2003         2002
                                                      ------------  -----------

Sales                                                  $   91,584     $ 75,993
Cost of sales                                              41,308       39,649
                                                      ------------  -----------
Gross profit                                               50,276       36,344
Selling, general and administrative
        Expenses                                          337,177      169,666
                                                      ------------  -----------
Net (loss) income before income
        taxes                                            (286,901)    (133,322)
Income tax  (benefit) expense                            (101,783)       4,059
                                                      ------------   ---------
Net (loss)                                             $ (388,684)    (129,263)
                                                      ============  ===========
Net (loss) income per common share                     $    (0.01)       ($.01)
                                                      ============  ===========
Weighted average number of
        common shares outstanding                      31,540,363    19,062,250
                                                      ============  ===========




The accompanying notes are an integral part of these consolidated
financial statements.                                                        F3

<PAGE>

                        On the Go Healthcare, Inc.
              Consolidated Statements of Shareholders' Equity
                   As of July 31, 2003 and July 31, 2002



<TABLE>
<CAPTION>
                              Common Stock      Treasury Stock           Additional                             Accumulated
                            Number    Amount   Number     Amount         paid in      Deficit    Comprehensive  other
                                                                         capital                 Loss           Comprehensive
                                                                                                                Loss
-----------------------------------------------------------------------------------------------------------------------------
<S>                    <C>            <C>     <C>           <C>         <C>        <C>          <C>            <C>

Balance July 31, 2001   17,858,500     1,786                              455,906    (186,868)                   (2,367)


Common stock issued,
  net of offering
  costs of $153,874        380,000        38                              (58,874)
Common stock issued
  for loans from
  related parties       11,000,000     1,100                               58,917
Common stock issued
  as compensation
  to Directors             375,000        38                                2,009
Net loss for the period                                                              (129,263)    (129,263)
Foreign currency
  translation adjustment                                                                           (16,122)     (16,122)
                        -----------------------------------------------------------------------------------------------------
Balance July 31, 2002   29,613,500     2,962                              457,958    (316,131)    (145,385)     (18,489)
                                                                                                  =========
Common stock issued as
  compensation for rent,
  salary, consulting
  and legal fees         8,040,000       804                              309,610
Net loss for the period                                                              (388,684)    (388,684)
Capital contribution                                                       12,842
Stock options issued                                                       13,665
Treasury stock acquired                        1,000,000      (21,243)
Foreign currency
  translation adjustment                                                                            17,524       17,524
                        -----------------------------------------------------------------------------------------------------
Balance July 31, 2003   37,653,500    $3,766   1,000,000     $(21,243)   $794,075   $(704,815)   $(371,160)     $  (965)
                        -----------------------------------------------------------------------------------------------------









</TABLE>

The accompanying notes are an integral part of the interim consolidated
financial statements.                                                        F4

<PAGE>


                                On the Go Healthcare, Inc.
                          Consolidated Statement of Cash Flows
                        For the years ended July 31, 2003 and 2002

                                                      ---------      ----------
                                                           2003           2002
                                                      ---------      ----------

Operating activities
Net loss                                              $(388,684)     $(129,263)
                                                      ---------      ----------
Adjustments to reconcile net loss to net cash used
  by operating activities:
    Amortization                                         19,876         32,179
    Shares issued in consideration of services
      rendered                                          288,942              0
    Stock options issued in consideration of services
      rendered                                           13,665          2,046
   (Increase) decrease in:
     Accounts receivable                                (12,452)        (5,207)
     Inventory                                          (22,842)       (25,093)
     Prepaid expenses                                  (112,463)             0
     Deferred income taxes                              101,783           (393)

  Increase (decrease) in:
    Accounts payable and accrued expenses                17,013        (38,200)
                                                      ---------      ----------
Total adjustments                                       293,522        (34,668)
                                                      ---------      ----------
Net cash used by operating activities                   (95,162)      (163,931)
                                                      ---------      ----------
Investing activities
                                                      ---------      ----------
  Net cash used by investing activities                       0              0
                                                      ---------      ----------
Financing activities
  Deferred offering costs                                     0         (9,794)
  Increase in bank indebtedness                          (2,100)        12,767
  Proceeds on sale of capital stock                           0         95,148
  Payments on loan payable to related party              (4,763)        (2,949)
  Proceeds from loan payable to related party           102,682         41,727
                                                      ---------      ----------
  Net cash provided by financing activities              95,819        136,899
                                                      ---------      ----------
Effect of exchange rate changes on cash                     105         (2,886)
                                                      ---------      ----------
Net (decrease) increase in cash                             762        (29,918)
Cash at beginning of period                                   0         29,918
                                                      ---------      ----------
Cash at end of period                                       762             $0
                                                      =========      ==========
Supplemental disclosures of cash flow information
Income taxes paid (refunded)                                  0        ($4,059)
                                                      ---------      ----------
Interest paid                                             2,434            918
                                                      ---------      ----------


The accompanying notes are an integral part of these consolidated
financial statements.                                                        F5

<PAGE>

                                On the Go Healthcare, Inc.
                       Notes to Consolidated Financial Statements
                               As of July 31, 2003 and 2002

1. Management's Plans

        The company's cash flow requirements are supported by loans from a
related party.

        Pursuant to an agreement for an equity line of credit, the company
has received approximately $188,000 during August and September 2003.

        Management believes that despite the recent losses and limited working
capital, it has developed a business plan that if successfully implemented, can
substantially improve operational results and its financial condition.

2. Background Information and Business Acquisition

        On the Go Healthcare, Inc. (On the Go) is a Delaware corporation
incorporated on July 21, 2000. The International Mount Company, LTD
(International Mount) was incorporated under the laws of Canada in August 1993.
On July 21, 2000, On the Go acquired International Mount in a business
combination accounted for in a manner similar to a pooling of interests since
it is a combination of entities under common control. International Mount
became a wholly owned subsidiary of On the Go via a cash payment of $198 and
the exchange of 16,000,000 shares of common stock of On the Go for all of
the outstanding stock of International Mount.

        The consolidated financial statements present the accounts of
On the Go Healthcare, Inc. and its wholly owned subsidiary, The International
Mount Company, LTD. The consolidated entities will hereinafter be referred to
as the Company. All significant inter-company accounts and transactions have
been eliminated.

        The Company is in the process of establishing its principal line of
business, the manufacturing and distribution of healthcare and childrens
products throughout the world. The Company's target customers are wholesalers
and retailers of healthcare and childrens products. The corporate headquarters
is located in Ontario, Canada.

        The company was listed on the Bulletin Board on February 5, 2003.


3. Significant Accounting Policies

        The significant accounting policies followed are:

        The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the consolidated financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates.

        The majority of cash is maintained with two major financial
institutions in Canada. Deposits with these banks may exceed the amount of
insurance provided on such deposits. Generally, these deposits may be redeemed
on demand and, therefore, bear minimal risk.

        The Company extends credit to its various customers based on the
customer's ability to pay. Based on management's review of accounts receivable,
an allowance for doubtful accounts has been recorded.

                                                                            F6
<PAGE>

        Inventory, consisting mainly of finished healthcare and childrens
products, is stated at the lower of cost (determined on an average cost basis)
or market.

        Plant and equipment are recorded at cost. Depreciation is calculated by
the declining-balance and straight-line methods over the estimated useful lives
of the assets, ranging generally from one to six years. Maintenance and repairs
are charged to operations when incurred. Betterments and renewals are
capitalized. When plant and equipment are sold or otherwise disposed of, the
asset account and related accumulated depreciation account are relieved, and
any gain or loss is included in operations.

        The Company follows Statement of Financial Accounting Standards Board
No. 121 (SFAS No. 121), Accounting for the Impairment of Long-Lived Assets and
for Long-Lived Assets to be Disposed Of. SFAS No. 121 requires that long-lived
assets and certain identifiable intangibles to be held and used by an entity
be reviewed for impairment whenever events or changes in circumstances indicate
that the carrying amount of these assets may not be recoverable. In performing
the review of recoverability, the Company estimates the future undiscounted
cash flows that are expected to result from the use of the assets and their
eventual disposition. Because events and circumstances frequently do not occur
as expected, there will usually be differences between the estimated and
actual future undiscounted cash flows, and these differences may be material.
If an asset is determined to be impaired, the Company recognizes a loss for
the difference between the carrying amount and the fair value of the asset.
The fair value of the asset is measured using quoted market prices or, in the
absence of quoted market prices, fair value is based on an estimate of
discounted cash flow analysis. During the periods presented, the Company
determined that its long lived assets were not impaired.

        The Company accounts for web site development costs in accordance with
FASB Emerging Issues Task Force Issue No. 00-2. This pronouncement concludes
that costs related to web site planning activities should be charged to
operations as incurred; costs incurred in the web site application and
infrastructure development stage should normally be accounted for pursuant
to Statement of Position 98-1, Accounting for the Costs of Software to be
Developed for Internal Use (SOP 98-1); fees incurred for web site hosting
should be charged to operations over the period of benefit; and costs
incurred in the operating stage should generally be expensed immediately.

        SOP 98-1 provides guidance on accounting for costs of computer
software developed for internal use. Costs associated with software developed
or obtained for internal use are capitalized when both the preliminary
project stage is completed and the Company's management has authorized further
funding of the project that it deems probable will be completed and used to
perform the function intended. Capitalized costs include only (1) external
direct costs of materials and services used in developing or obtaining
internal-use software, (2) payroll and payroll related costs for employees
who are directly associated with and who devote time to the internal use
software project, and (3) interest costs incurred, when material, while
developing internal use software. Capitalization of such costs ceases no
later than the point at which the project is substantially complete and is
ready for its intended purpose.

        Software development costs are being amortized on the straight-line
basis over a period of two years. Research and development costs and other
computer software maintenance costs related to software development are
expensed as incurred. For the year ended July 31, 2001, the Company capitalized
approximately $17,000 of costs related to the development of the Company's
web site.

                                                                            F7
<PAGE>

        Foreign currency translation adjustments arise from the translation
of the functional currency of International Mount (Canadian dollars) into the
reporting currency of On the Go (U.S. dollars). The balance sheet is translated
at the exchange rate in effect at the balance sheet date, while the statement
of operations is translated at the average rates of exchange during the period.
The resulting translation adjustments are recorded directly to accumulated
other comprehensive income (loss).

        Foreign currency transaction gains and losses represent gains and
losses resulting from transactions entered into in currencies other than the
functional currency of International Mount (Canadian dollars). These
transaction gains and losses are included in results of operations.

        Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to differences between the consolidated
financial statements carrying amounts of existing assets and liabilities and
their respective income tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be recovered or
settled. The effect on deferred tax assets and liabilities of a change in tax
rates is recognized as income in the period that included the enactment date.
Deferred tax assets are evaluated to determine if the benefit is more likely
than not to be realized. If required a valuation allowance is recorded to
reduce the value of deferred tax assets to reflect a valuation allowance.

        Offering costs associated with the sale of stock are capitalized and
offset against the proceeds of the offering or expensed if the offering is
unsuccessful.

        Basic earnings (loss) per common share is calculated by dividing net
earnings (loss) by the average number of common shares outstanding during the
year. Diluted earnings (loss) per common share is calculated by adjusting
outstanding shares, assuming conversion of all potentially dilutive stock
options. There are no potentially dilutive stock options outstanding for the
periods presented.

        In December 1995, SFAS No. 123, Accounting for Stock-Based
Compensation, was issued. It introduced the use of a fair value-based method
of accounting for stock-based compensation. It encourages, but does not
require, companies to recognize stock-based compensation expenses to employees
based on the new fair value accounting rules. Companies that choose not to
adopt the new rules will continue to apply the existing accounting rules
continued in Accounting Principles Board Option No. 25, Accounting for stock
issued to employees. However, SFAS No. 123 requires companies that choose not
to adopt the new fair value accounting rules to disclose pro forma net income
and earnings per share under the new method. SFAS No. 123 is effective for
financial statements for fiscal years beginning after December 31, 1995. The
company has adopted the disclosure provisions of SFAS No. 123.

        The Company recognizes revenue when title of goods passes to the
customer (generally upon shipment).

        The Company records amounts billed to customers for shipping and
handling costs as sales revenue. Costs incurred by the Company for shipping
and handling are included in cost of sales.

        The Company offers discounts and point-of-sale rebates to its customers
on its products. The costs of these discounts and point-of-sale rebates are
recognized at the date at which the related sales revenue is recognized and
are recorded as a reduction of sales revenue.

        Advertising costs are charged to operations when the advertising first
takes place. Advertising expense for the years ended July 31, 2003 and 2002
amounted to $1,917 and  $4,739  respectively. The Company has not incurred any
direct-response advertising costs.

                                                                            F8
<PAGE>

4. Accounts receivable

                                                   2003         2002
                                                -------      -------
        Accounts receivable                     $22,122      $ 8,203
        Provision for doubtful accounts             362            -
                                                -------      -------
        Accounts receivable, net                $21,760      $ 8,203
                                                -------      -------


5. Plant and Equipment

        Plant and equipment consist of the following as of July 31;

                                                   2003         2002
                                                -------      -------
        Machinery and equipment                 $75,347      $75,347
        Office equipment                         10,074       10,074
        Computer software                         9,942        9,942
        Computer hardware                         2,261        2,261
        Leasehold improvements                    4,854        4,854
                                                -------      -------
                                                102,478      102,478
        Less accumulated depreciation            62,311       52,103
                                                -------      -------
                                                $40,167      $50,375
                                                =======      =======


        Depreciation expense for Plant and Equipment for the years July 31,2003
and 2002 were $19,876 and $32,179 respectively.


6. Bank indebtedness

        The company has a line of credit in the amount of $18,000 that bears
interest a the bank's prime lending rate plus 1/4% per annum. The line of
credit is secured by a general assignment of book debts and the personal
guarantee of one of the directors.


7. Notes Payable and Other Related Party Transactions

        Notes payable to related parties at July 31, 2003 in the amount of
$125,947  (July 31, 2002 -$20,846) consist of amounts due to stockholders and
affiliated companies. These notes are non-interest bearing, unsecured, and have
been recorded on a non-discounted basis. As of July 31, 2003, the balance of
$125,947 is not required to be repaid prior to August 1, 2004 and, therefore,
is classified as a long-term liability on the accompanying consolidated balance
sheet.

        Accounts payable and accrued expenses includes accrued expenses due to
a related party in the amount of nil (2002 - $12,622).

        The above terms and amounts are not necessarily indicative of the terms
and amounts that would have been incurred had comparable transactions been
entered into with independent parties. The terms of these transactions were
more favorable than would have been attained if the transactions were
negotiated at arms length.

                                                                            F9
<PAGE>

8. Common Stock


        During the year ended July 31, 2001, the Company issued 1,858,500
shares of its common stock for proceeds of $452,521, net of offering costs of
$11,918, under a private placement offering.

        During the year ended  July 31, 2002, the Company issued 380,000 common
shares at a price of $.25 per share. Issue costs totaling $153,874 were charged
against the proceeds of this share issuance.

        On July 1, 2002, the company issued 11,000,000 common shares in
settlement of a loan payable to a related party in the amount of $60,017.

        On July 1, 2002, the company issued 75,000 common shares to each of
5 directors of the company for a total issuance of 375,000. The amount of
$2,047 has been included in Selling, General and Administrative expenses.

        The company issued 1,000,000 common shares to consultants on
January 31, 2003. The services to be provided include general financial
advisory services, investment banking services, management of sales force
and retail base initiatives, the right to use photo images, and EDI services.
The shares were recorded at the estimated value of the services rendered or
to be rendered, an amount of $21,404, which is the value which is more readily
available.

        In addition, the company issued 125,000 shares to its legal counsel
for legal services rendered to July 31, 2002 for a total cost of $2,675 which
is the estimated value of the services rendered.

        The principle shareholder agreed to forego management salaries payable
in the amount of $12,842. This amount has been treated as a capital
contribution as of January 31, 2003.

        The company issued 4,810,000 common shares during the 3rd quarter for
consulting services to be provided over a period of one year, management
salaries and rental of equipment for the quarter and rent for the period
November 1, 2002 to January 31, 2004. The shares were recorded at the value of
the shares at the date of issue and a total of $108,200 has been reflected as
the consideration for the shares issued.

        The company issued 1,500,000 common shares during the 4th quarter for
consulting services to be provided over a period of one year. The shares were
recorded at the value of the shares at the date of issue and a total of
$125,500 has been reflected as the consideration for the shares issued.

        On July 31, 2003, the company issued 75,000 common shares to each of
5 directors of the company for a total issuance of 375,000 and 230,000 shares
to Stuart Turk in consideration of salary for a total of 605,000 shares. The
amount of $52,635 has been included in Selling, General and Administrative
expenses.

9. Stock options

        The company issued 650,000 options exercisable for one year until
April 24, 2004 at an exercise price of $.20 per share. The value of the options
has been estimated to be $1,387 using a risk-free interest rate of 1.27%,
expected life of 1 year, expected dividend yield of 0% and an expected
volatility of 150%.

        On July 15, 2003, a consultant was issued an option to acquire 200,000
common shares at an exercise price of $.05 per share with an expiry of
July 15, 2005. The option was issued in consideration of services rendered to
the company. The value of the option has been estimated to be $12,278 computed
based on the Black Scholes model, using a fair market value price of $.082 per
share, volatility of 137% and a riskless interest rate of 1.35%.

                                                                            F10
<PAGE>

10. Net loss per share

        Basic earnings per share is computed by dividing net loss by the
weighed average number of shares of common stock outstanding during the period.
Diluted earnings per shares is computed by dividing net loss by the weighted
average number of common and dilutive common equivalent shares outstanding
during the period. Common equivalent shares consider of shares of common stock
issuable upon the exercise of stock options; common equivalent shares are
excluded from the calculation if their effect is antidilutive. The company has
excluded  850,000 shares related to options.

11. Lease Commitments

        The company has signed a lease agreement with a related party for the
period November 1, 2002 to January 31, 2004 for the issuance of 10,000 common
shares per month in lieu of rent. 150,000 shares have been issued in
satisfaction of this agreement

        Rent expense amounted to $14,000 and $19,000 for the years ended
July 31, 2003 and 2002, respectively.

        The above related party lease transaction is not necessarily indicative
of the amounts that would have been incurred had a comparable transaction been
entered into with an independent party. The terms of this transaction were more
favorable than would have been attained if the transactions were negotiated at
arms length.


12. Income Taxes

        On the Go Healthcare, Inc. is a corporation that reports and files a
U.S. corporation business tax return. The Company's wholly owned subsidiary,
The International Mount Company, LTD, is a corporation that reports and files
its corporate business tax return with the Canada Customs and Revenue Agency,
which governs the administration of income taxes for Canada. The components of
the provision for income tax (benefit) expense consist of:

                                        2003         2002
                                   ----------    ---------
                Foreign            $(101,783)     $(4,059)


        The Company has a Canadian tax operating loss carryforward of
approximately $650,000 that expires in the years 2008 to 2010.


        The principal reason that the aggregate income tax provision is
different from that computed by using the U.S. statutory rate of 34 percent
is as follows:

                                                    2003         2002
                                               ----------    ---------
        US statutory rate                       (132,153)     (45,329)
        Changes in tax resulting from foreign
           Income tax at rates other than US
           Statutory rate                        (23,321)     (12,343)
        Increase in valuation allowance          257,257       53,613
                                               ----------    ---------
                                                $101,783      $(4,059)
                                               ----------    ---------


        In assessing the necessity for a valuation allowance for deferred
tax assets, management considers whether it is "more likely than not" that
some portion or all of these future deductible amounts will be realized as
a refund or reduction in current taxes payable. Management has not recorded
the full benefit of these deferred tax assets due to the uncertainty related
to these future deductible amounts. The ultimate realization of deferred tax
assets is dependent upon the existence of, or generation of, taxable income
in the periods in which those temporary differences are deductible. Management
considers the scheduled reversal of deferred tax liabilities, projected future
taxable income, and tax planning strategies in making this assessment.

                                                                            F11
<PAGE>

13. Cash flow

        As of January 31, 2003,  management salaries aggregating $12,842 have
been forgiven and this amount credited to additional paid in capital. As this
was a non-cash transaction, the statement of cash flows does not include the
following;

                                                                2003      2002
                                                           ---------  ---------
    Reduction in accounts payable                          ($12,842)   (60,017)
    Additional paid in capital due to capital contribution  $12,842
    Issuance of capital stock                                           60,017

14. Commitment

        On July 21, 2003, the company signed an agreement for the issuance of
common shares pursuant to an equity line of credit agreement. The quantity of
shares to be issued will be limited by the volume of shares traded and the
price will be determined at 94% of the average of the three lowest closing best
bids during the pricing period. The maximum accessible through this facility
if $2,500,000.


15. Subsequent events

        During August 2003, the company issued 1,623,817 common shares for a
total consideration of $157,900. The difference between the fair market value
of the shares at the time of their issue and the proceeds received on the
issuance, $11,003,  will be treated as a financing expense and charged to
selling, general and administrative expenses.

During September 2003, the company issued 361,905 common shares for a
total consideration of $30,000. The difference between the fair market value
of the shares at the time of their issue and the proceeds received on the
issuance, $5,444,  will be treated as a financing expense and charged to
selling, general and administrative expenses.

                                                                            F12
<PAGE>